Risk of bias in industry-funded oseltamivir trials: comparison of core reports versus full clinical study reports

BACKGROUND: The Cochrane risk of bias tool is a prominent instrument used to evaluate potential biases in clinical trials. In three updates of our Cochrane review on neuraminidase inhibitors, we assessed risk of bias on the same trials using different levels of detail: the trials in journal publicat...

Descripción completa

Detalles Bibliográficos
Autores principales: Jefferson, Tom, Jones, Mark A, Doshi, Peter, Del Mar, Chris B, Hama, Rokuro, Thompson, Matthew J, Onakpoya, Igho, Heneghan, Carl J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2014
Materias:
Evidence Based Practice
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4179405/
https://www.ncbi.nlm.nih.gov/pubmed/25270852
http://dx.doi.org/10.1136/bmjopen-2014-005253

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4179405/
https://www.ncbi.nlm.nih.gov/pubmed/25270852
http://dx.doi.org/10.1136/bmjopen-2014-005253

Ejemplares similares